Companies: 10,795·Total market cap: $144.5T

Editas Medicine, Inc.

Editas Medicine, Inc.

EDITNASDAQHealthcare● Active

$2.65

$-0.07(-2.40%)

Market Cap$258946127

P/E Ratio—

52W High$4.537

52W Low$1.66

Avg Volume2.1M

Open$2.76

Beta2.10

Editas Medicine, Inc. (EDIT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

EDIT · net income · updated Jun 9, 2026

Core profitability metrics

EDIT · net income · margin · TTM · CAGR

Net income was −$160.1M for FY2025 (fiscal year ending 2025-12-31), up 32.5% year-over-year. Net profit margin was -395.0%.

FY2025 Net Income−$160.1M▲ +32.5% YoY

Trailing 12M (TTM)−$109.0Mtrailing 4 quarters sum

Net Profit Margin-395.0%−$160.1M ÷ $40.5M

YoY Change+32.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · EDIT net income history · EDIT profit margin

Annual net income data

EDIT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$160.1M▲ +32.5%-395.0%$40.5M

FY2024Loss−$237.1M▼ 54.7%-733.7%$32.3M

FY2023Loss−$153.2M▲ +30.5%-196.1%$78.1M

FY2022Loss−$220.4M▼ 14.5%-1118.3%$19.7M

FY2021Loss−$192.5M▼ 66.0%-753.6%$25.5M

Net income vs peers (Healthcare)

EDIT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Editas Medicine, Inc.YOU

EDIT

−$160.1M+32.5%-395.0%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Editas Medicine, Inc. (EDIT) reported net income of −$160.1M for FY2025 (fiscal year ending 2025-12-31), up 32.5% year-over-year. The net profit margin was -395.0% — meaning the company kept $-3.95 of every dollar of revenue as profit.

Editas Medicine, Inc. has not yet achieved annual profitability based on available data (13 fiscal years). The company has reported net losses across all available periods.

Editas Medicine, Inc.'s net profit margin was -395.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Editas Medicine, Inc. net worth" — the company's market capitalization is a separate figure from EDIT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

EDIT net income · 4 questions

Editas Medicine, Inc. is not currently profitable on an annual basis. The company reported a net loss of $160.1M for FY2025.

is EDIT profitabledoes EDIT make a profitEDIT profitabilityEDIT profitable company

▸ Source: FMP /income-statement · GAAP · Editas Medicine, Inc. · Editas Medicine, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026